Difference between revisions of "Project:Updates Switch Tables"
From Psychiatrienet
(→March 2024) |
|||
| Line 1: | Line 1: | ||
=== Updates Switch Tables === | === Updates Switch Tables === | ||
===== March 2024 ===== | ===== March 2024 ===== | ||
| − | * Antidepressants: Reviewed and updated switches to tranylcypromine, fluoxetine and moclobemide (not finished) | + | * Antidepressants: Reviewed and updated switches to tranylcypromine, fluoxetine and moclobemide (not finished) |
| + | * Updated e-mail: medisch@boom.nl | ||
===== August 2023 ===== | ===== August 2023 ===== | ||
Latest revision as of 10:51, 12 March 2024
Contents
Updates Switch Tables
March 2024
- Antidepressants: Reviewed and updated switches to tranylcypromine, fluoxetine and moclobemide (not finished)
- Updated e-mail: medisch@boom.nl
August 2023
- Antidepressants: Reviewed and updated switches from and to agomelatine, moclobemide and bupropion (not finished).
June 2023
- Antidepressants: Reviewed and updated switches from TCA to SSRI and SSRI to TCA (not finished)
February 2023
- Antidepressants: Reviewed and updated switches from SSRI to SSRI and SSRI to SNRI (not finished)
- Changed reference of literature in switch table
March 2022
- Antipsychotics: Certain long acting to long acting switches deleted.
- Antipsychotics: oral to different antipsychotic long acting deleted.
- Antipsychotics: added penfluridol
- Antipsychotics: added paliperidone extended release formulations (Xeplion, Trivecta, Byannli)
- Antipsychotics: ziprasidone moved to rest AP
- Antipsychotics: paliperidone moved from rest AP
- Introduced Updates Switch Tables page for informing users about changes on the Switchwiki
October 2021
- Antipsychotics: added group partial antagonists
If you any have suggestions, please send them to info@tijdstroom.nl. We are looking forward to your feedback.
